An ELISA for the measurement of human leukemia inhibitory factor in biological fluids and culture supernatants.

[1]  K. J. Kim,et al.  Detection of human leukemia inhibitory factor by monoclonal antibody based ELISA. , 1992, Journal of immunological methods.

[2]  M. Jadoul,et al.  Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis , 1992 .

[3]  L. D. Ward,et al.  A major binding protein for leukemia inhibitory factor in normal mouse serum: identification as a soluble form of the cellular receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Y. Ishimi,et al.  Leukemia inhibitory factor/differentiation‐stimulating factor (LIF/D‐factor): Regulation of its production and possible roles in bone metabolism , 1992, Journal of cellular physiology.

[5]  D. de Groote,et al.  Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. , 1992, Cytokine.

[6]  J. Moreau,et al.  HILDA/LIF URINARY EXCRETION DURING ACUTE KIDNEY REJECTION , 1992, Transplantation.

[7]  J. Winer,et al.  Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: identification as leukemia inhibitory factor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  C. Stewart,et al.  Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Ohno,et al.  Rapid colorimetric assay for the quantification of leukemia inhibitory factor (LIF) and interleukin-6 (IL-6). , 1991, Journal of immunological methods.

[10]  I. Reid,et al.  Regulation of osteoblast proliferation by leukemia inhibitory factor , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  I. Anegon,et al.  Regulation of HILDA/LIF gene expression in activated human monocytic cells. , 1991, Journal of immunology.

[12]  G. Nabel,et al.  Tumor necrosis factor-alpha, interleukin 1, and phorbol myristate acetate are independent activators of NF-kappa B which differentially activate T cells. , 1991, Cytokine.

[13]  W. Buurman,et al.  Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids , 1991, The Lancet.

[14]  T. Yamamori.  Localization of cholinergic differentiation factor/leukemia inhibitory factor mRNA in the rat brain and peripheral tissues. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Z. Estrov,et al.  LIF: not just a leukemia inhibitory factor. , 1991, Endocrine reviews.

[16]  I. Anegon,et al.  Control of HILDA/LIF Gene Expression in Activated Human Monocytes a , 1991, Annals of the New York Academy of Sciences.

[17]  D. Hilton,et al.  Leukemia inhibitory factor can potentiate murine megakaryocyte production in vitro. , 1991, Blood.

[18]  D. Hilton,et al.  Leukemia inhibitory factor: A biological perspective , 1991, Journal of cellular biochemistry.

[19]  S. Madersbacher,et al.  Double wavelength measurement of 3,3',5,5'-tetramethylbenzidine (TMB) provides a three-fold enhancement of the ELISA measuring range. , 1991, Journal of immunological methods.

[20]  A. Burgess,et al.  Stimulation of myoblast proliferation in culture by leukaemia inhibitory factor and other cytokines , 1991, Journal of the Neurological Sciences.

[21]  J. Moreau,et al.  Production of human interleukin for DA cells (HILDA)/leukemia inhibitory factor (LIF) by activated monocytes. , 1990, Cellular immunology.

[22]  D. Hilton,et al.  Leukemia inhibitory factor binds with high affinity to preosteoblastic RCT-1 cells and potentiates the retinoic acid induction of alkaline phosphatase. , 1990, Endocrinology.

[23]  G. Rodan,et al.  Leukemia inhibitory factor suppresses proliferation, alkaline phosphatase activity, and type I collagen messenger ribonucleic acid level and enhances osteopontin mRNA level in murine osteoblast-like (MC3T3E1) cells. , 1990, Endocrinology.

[24]  J. Cavaillon,et al.  Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide , 1990, Infection and immunity.

[25]  A. Smith,et al.  Leukemia inhibitory factor differentiation-inhibiting activity/human interleukin for DA cells augments proliferation of human hematopoietic stem cells. , 1990, Blood.

[26]  V. Praloran,et al.  Characterization and NH2-terminal amino acid sequence of natural human interleukin for DA cells: leukemia inhibitory factor. Differentiation inhibitory activity secreted by a T lymphoma cell line. , 1989, The Journal of biological chemistry.

[27]  R. Aebersold,et al.  The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. , 1989, Science.

[28]  R. Williams,et al.  The pleiotropic actions of leukemia inhibitory factor. , 1989, Cancer cells.

[29]  K. Yamaguchi,et al.  Purification of a lipoprotein lipase-inhibiting protein produced by a melanoma cell line associated with cancer cachexia. , 1989, Biochemical and biophysical research communications.

[30]  P. Vereerstraeten,et al.  RELEASE OF TUMOR NECROSIS FACTOR, INTERLEUKIN‐2, AND GAMMA‐INTERFERON IN SERUM AFTER INJECTION OF OKT3 MONOCLONAL ANTIBODY IN KIDNEY TRANSPLANT RECIPIENTS , 1989, Transplantation.

[31]  Donald Metcalf,et al.  Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells , 1988, Nature.

[32]  J. Moreau,et al.  Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells , 1988, Nature.

[33]  P. Lipsky,et al.  T4 cell activation by immobilized phytohemagglutinin: differential capacity to induce IL-2 responsiveness and IL-2 production. , 1988, Journal of immunology.

[34]  J. Moreau,et al.  Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cells. , 1988, Blood.

[35]  D. Hilton,et al.  Molecular cloning and expression of the human homologue of the murine gene encoding myeloid leukemia-inhibitory factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Bonneville,et al.  Characterization of a factor produced by human T cell clones exhibiting eosinophil-activating and burst-promoting activities. , 1987, Journal of immunology.

[37]  A. Smith,et al.  Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. , 1987, Developmental biology.

[38]  Y. Yamamoto‐Yamaguchi,et al.  Purification of a factor inducing differentiation of mouse myeloid leukemic M1 cells from conditioned medium of mouse fibroblast L929 cells. , 1984, The Journal of biological chemistry.

[39]  P. Nakane,et al.  PEROXIDASE-LABELED ANTIBODY A NEW METHOD OF CONJUGATION , 1974, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[40]  M. Jadoul,et al.  Generation of monoclonal antibodies against HILDA/LIF and their use in the quantitative assay of the cytokine. , 1993, Cytokine.

[41]  J. Falkenburg,et al.  Human interleukin for DA cells (HILDA) does not affect the proliferation and differentiation of hematopoietic progenitor cells in human long-term bone marrow cultures. , 1992, Experimental hematology.

[42]  J. Moreau,et al.  HILDA/LIF is present in the urine of rejecting kidney graft recipeints , 1992 .

[43]  D. Metcalf.  The leukemia inhibitory factor (LIF). , 1991, International journal of cell cloning.